A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and confirm the safety of E0302 in
patients with Amyotrophic Lateral Sclerosis (ALS) by assessing changes in scores of survival
rate and functional rating scale.